Formulary Decisions

Search for the outcome of decisions made by the Formulary Committee

Filter
Select filter(s)
Rimegepant
Vydura
Routinely available
SMC (SMC2603)
07/08/2024

Indication

For the preventive treatment of episodic migraine in adults who have at least four migraine attacks per month. SMC restriction: for patients with episodic migraine who have at least 4 migraine attacks per month, but fewer than 15 headache days per month and who have had prior failure on three or mor...

For the preventive treatment of episodic migraine in adults who have at least four migraine attacks per month. SMC restriction: for patients with episodic migraine who have at least 4 migraine attacks per month, but fewer than 15 headache days per month and who have had prior failure on three or more migraine preventive treatments.

Therapeutic Area

Central nervous system

Status Description

Routinely available in line with national guidance

Formulation

Oral lyophilisate

Comments

Link to Advice

SMC2603

Advice Published

11/09/2023

SMC Submission Type

Resubmission

SMC Status

Restricted